Atlas Trials

Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin

Clinical trial NCT01823679 · TERMINATED

Trial details

NCT number
NCT01823679
Sponsor
Stanford University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Squamous Cell Carcinoma of the SkinRecurrent Skin Cancer
Start date
2013-03-01
Primary completion
2014-05-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.